Eiger BioPharmaceuticals Reports Inducement Grant Under Nasd

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of...

Related Keywords

, European Medicines Agency , Eiger Biopharmaceuticals Inc , Compensation Committee Of Eiger Board Directors , Nasdaq , Eiger Biopharmaceuticals , Erik Atkisson , General Counsel , Chief Compliance Officer , Compensation Committee , Nasdaq Listing Rule , Hepatitis Delta Virus , Hutchinson Gilford Progeria Syndrome , Marketing Authorization Application , Nc ,